Spain establishes "voluntary" centralised medtech purchasing
This article was originally published in Clinica
This week's passage in Spain of law 8/2010 on the reduction of the public deficit will see the creation of a national centralised healthcare products purchasing system. The move had been agreed unanimously by the inter-territorial council of the national health system (of central and regional governments) on 18 March 2010. Adoption of the system on the part of the regional authorities is voluntary, said the health ministry in a statement. However, the health ministry described the decision to centralise purchasing as "one of the most important taken [during the 18 March meeting] for making the national health system more efficient and sustainable".
You may also be interested in...
US investigators fan out to non-China inspection priorities and Secretary Azar talks supply management; warning letters hit record keeping, investigations and basic GMP compliance.
Mallinckrodt to pay $1.6bn and place its generics unit in bankruptcy under agreement in principle for US global settlement; six states are not on board, including New York, whose suit is still set to go to trial March 20.
The company has reached a broad opioid settlement agreement in principle under which its specialty generics subsidiaries would file for Chapter 11 bankruptcy and Mallinckrodt's branded business would operate separately.